See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2017_NeuBase_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001173281', 'EntityCommonStockSharesOutstanding': 35961396, 'Assets': 29445013, 'AssetsCurrent': 13285008, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 15949131, 'Liabilities': 4481866, 'LiabilitiesAndStockholdersEquity': 29445013, 'LiabilitiesCurrent': 4481866, 'LiabilitiesNoncurrent': 0, 'NetIncome': -25766198, 'PropertyPlantAndEquipmentNet': 198631, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 12243, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 24963147, 'remainder_NetIncome': -25766198, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001173281')"} |
Edgar->Model Mapping
